Minocycline Impact on Redox Homeostasis of Normal Human Melanocytes HEMn-LP Exposed to UVA Radiation and Hydrogen Peroxide.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
06 Feb 2021
Historique:
received: 30 12 2020
revised: 02 02 2021
accepted: 03 02 2021
entrez: 10 2 2021
pubmed: 11 2 2021
medline: 4 9 2021
Statut: epublish

Résumé

Minocycline is a semisynthetic tetracycline antibiotic. In addition to its antibacterial activity, minocycline shows many non-antibiotic, beneficial effects, including antioxidative action. The property is responsible, e.g., for anti-inflammatory, neuroprotective, and cardioprotective effects of the drug. However, long-term pharmacotherapy with minocycline may lead to hyperpigmentation of the skin. The reasons for the pigmentation disorders include the deposition of the drug and its metabolites in melanin-containing cells and the stimulation of melanogenesis. The adverse drug reaction raises a question about the influence of the drug on melanocyte homeostasis. The study aimed to assess the effect of minocycline on redox balance in human normal melanocytes HEMn-LP exposed to hydrogen peroxide and UVA radiation. The obtained results indicate that minocycline induced oxidative stress in epidermal human melanocytes. The drug inhibited cell proliferation, decreased the level of reduced thiols, and stimulated the activity of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). The described changes were accompanied by an increase in the intracellular level of ROS. On the other hand, pretreatment with minocycline at the same concentrations increased cell viability and significantly attenuated the oxidative stress in melanocytes exposed to hydrogen peroxide and UVA radiation. Moreover, the molecular docking analysis revealed that the different influence of minocycline and other tetracyclines on CAT activity can be related to the location of the binding site.

Identifiants

pubmed: 33561995
pii: ijms22041642
doi: 10.3390/ijms22041642
pmc: PMC7914767
pii:
doi:

Substances chimiques

Antioxidants 0
Melanins 0
Sulfhydryl Compounds 0
Hydrogen Peroxide BBX060AN9V
Catalase EC 1.11.1.6
Glutathione Peroxidase EC 1.11.1.9
Superoxide Dismutase EC 1.15.1.1
Minocycline FYY3R43WGO

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Śląski Uniwersytet Medyczny
ID : KNW-2-O26/N/9/K and KNW-1-037/K/9/O

Références

Int J Mol Med. 2017 Apr;39(4):869-878
pubmed: 28260081
Toxicol In Vitro. 2020 Jun;65:104790
pubmed: 32044399
Int J Mol Sci. 2020 May 12;21(10):
pubmed: 32408543
Oxid Med Cell Longev. 2017;2017:4310469
pubmed: 28246551
Food Chem Toxicol. 2015 Apr;78:10-6
pubmed: 25656643
Ann Pharmacother. 2021 Jan;55(1):105-110
pubmed: 32618475
Evid Based Complement Alternat Med. 2012;2012:680834
pubmed: 22956976
Mol Cell Biochem. 2015 Mar;401(1-2):107-14
pubmed: 25433710
Neurochem Res. 2014 Jul;39(7):1270-8
pubmed: 24756376
J Am Acad Dermatol. 2006 Feb;54(2):258-65
pubmed: 16443056
J Clin Med. 2017 Feb 20;6(2):
pubmed: 28230726
Eur J Pharmacol. 2011 Nov 1;669(1-3):32-7
pubmed: 21871884
Mol Aspects Med. 2009 Feb-Apr;30(1-2):77-85
pubmed: 19232542
Nat Rev Mol Cell Biol. 2020 Jul;21(7):363-383
pubmed: 32231263
Oxid Med Cell Longev. 2016;2016:2721469
pubmed: 27006746
Methods Mol Biol. 2015;1263:243-50
pubmed: 25618350
Biochem J. 2000 Apr 15;347(Pt 2):543-51
pubmed: 10749685
Int J Mol Med. 2008 Jul;22(1):9-16
pubmed: 18575770
Sci Rep. 2017 Feb 09;7:41712
pubmed: 28181523
J Psychopharmacol. 2013 Nov;27(11):1032-43
pubmed: 24045882
Chem Biol Interact. 2019 Apr 25;303:27-34
pubmed: 30768968
Toxicol Res. 2017 Jan;33(1):43-48
pubmed: 28133512
Toxicol In Vitro. 2013 Apr;27(3):1102-8
pubmed: 23416261
Biology (Basel). 2020 Mar 21;9(3):
pubmed: 32245238
Brain Res Bull. 2017 May;131:207-213
pubmed: 28454931
Cardiovasc Toxicol. 2013 Sep;13(3):301-6
pubmed: 23504614
Eur J Med Chem. 2015 Jun 5;97:55-74
pubmed: 25942353
J Invest Dermatol. 2006 Dec;126(12):2565-75
pubmed: 17108903
Acta Dermatovenerol Croat. 2009;17(2):123-6
pubmed: 19595269
Redox Rep. 2016 Jul;21(4):164-9
pubmed: 26020527
J Nutr Health Aging. 2019;23(8):694-699
pubmed: 31560025
Int J Womens Dermatol. 2020 Mar 26;6(4):331-333
pubmed: 33015298
An Bras Dermatol. 2017 May-Jun;92(3):356-362
pubmed: 29186248
Free Radic Biol Med. 2016 Nov;100:86-93
pubmed: 27154978
Am J Physiol Cell Physiol. 2010 Sep;299(3):C539-48
pubmed: 20592239
J Clin Invest. 2003 Mar;111(6):785-93
pubmed: 12639981
J Community Hosp Intern Med Perspect. 2014 Jul 31;4:
pubmed: 25147636
Curr Mol Med. 2018;18(3):142-151
pubmed: 30198433
Cell. 2015 Jul 30;162(3):540-51
pubmed: 26232224
QJM. 2017 May 1;110(5):323
pubmed: 28339809
FASEB J. 2017 Sep;31(9):3729-3745
pubmed: 28592639
mBio. 2011 Sep 06;2(5):
pubmed: 21896680
J Neurochem. 2005 Aug;94(3):819-27
pubmed: 16033424
Biochem Biophys Res Commun. 2009 Aug 21;386(2):322-6
pubmed: 19523448
Int J Mol Sci. 2020 Mar 18;21(6):
pubmed: 32197410
J Antimicrob Chemother. 2006 Aug;58(2):256-65
pubmed: 16816396
An Bras Dermatol. 2013 Jan-Feb;88(1):76-83
pubmed: 23539007
Photochem Photobiol. 2015 Nov;91(6):1429-34
pubmed: 26189561
Antioxid Redox Signal. 2002 Aug;4(4):665-73
pubmed: 12230879
Antioxidants (Basel). 2019 Aug 01;8(8):
pubmed: 31374936
Molecules. 2020 Mar 27;25(7):
pubmed: 32230973
J Clin Biochem Nutr. 2010 May;46(3):224-8
pubmed: 20490317
J Lipid Res. 1996 Jul;37(7):1436-48
pubmed: 8827516
Can J Physiol Pharmacol. 2015 Oct;93(10):863-6
pubmed: 26382908
J Photochem Photobiol B. 2015 Jul;148:168-173
pubmed: 25935746
Yakugaku Zasshi. 2011;131(5):731-8
pubmed: 21532269
Biomed Rep. 2016 May;4(5):519-522
pubmed: 27123241
J Cosmet Laser Ther. 2013 Apr;15(2):107-13
pubmed: 23384037
J Med Biochem. 2018 Jan 01;37(1):12-20
pubmed: 30581337
Free Radic Biol Med. 1999 Mar;26(5-6):518-25
pubmed: 10218640
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
J Drugs Dermatol. 2012 Jun;11(6):742-6
pubmed: 22648222
Mol Cell Biochem. 2013 Nov;383(1-2):77-84
pubmed: 23867989
Redox Rep. 2009;14(4):154-8
pubmed: 19695122
Basic Clin Pharmacol Toxicol. 2017 Jun;120(6):515-522
pubmed: 28027430
Luminescence. 2012 Jul-Aug;27(4):249-55
pubmed: 22887986
Australas J Dermatol. 2014 May;55(2):111-8
pubmed: 23808657
J Mol Biol. 2000 Feb 11;296(1):295-309
pubmed: 10656833
Br J Pharmacol. 2013 May;169(2):337-52
pubmed: 23441623
Neurochem Int. 2009 Jun;54(7):464-70
pubmed: 19428790
Int J Pharm. 2002 Mar 20;235(1-2):219-27
pubmed: 11879756
Biomolecules. 2019 May 30;9(6):
pubmed: 31151226
J Cell Biochem. 2013 Dec;114(12):2746-52
pubmed: 23804282
Mini Rev Med Chem. 2012 Jan;12(1):44-52
pubmed: 22070692
Dermatol Ther. 2010 May-Jun;23(3):305-7
pubmed: 20597950
Pharmacol Res. 2013 Jan;67(1):18-30
pubmed: 23085382
J Cheminform. 2011 Oct 07;3:33
pubmed: 21982300
Int J Mol Sci. 2016 Jul 15;17(7):
pubmed: 27428965
Psychosom Med. 2014 Jan;76(1):12-9
pubmed: 24336428
Biophys Chem. 2006 Jan 20;119(2):137-45
pubmed: 16139945
Cell Syst. 2019 Feb 27;8(2):163-167.e2
pubmed: 30797774
Protein Cell. 2010 Oct;1(10):888-97
pubmed: 21204015
Open Biochem J. 2013 Apr 19;7:44-53
pubmed: 23730364
Oxid Med Cell Longev. 2011;2011:809696
pubmed: 21904647
J Bioenerg Biomembr. 2010 Apr;42(2):151-63
pubmed: 20180001
FEBS J. 2009 Mar;276(6):1729-38
pubmed: 19243427
Open Dent J. 2008;2:5-12
pubmed: 19088876
Indian J Dermatol Venereol Leprol. 2014 Jan-Feb;80(1):29-35
pubmed: 24448120
J Biol Chem. 2011 Feb 18;286(7):4991-5002
pubmed: 21081502
PLoS One. 2009 Jul 29;4(7):e6413
pubmed: 19641610
Inflammopharmacology. 2011 Apr;19(2):99-110
pubmed: 21350981

Auteurs

Jakub Rok (J)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 41-200 Sosnowiec, Poland.

Zuzanna Rzepka (Z)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 41-200 Sosnowiec, Poland.

Mateusz Maszczyk (M)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 41-200 Sosnowiec, Poland.

Artur Beberok (A)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 41-200 Sosnowiec, Poland.

Dorota Wrześniok (D)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 41-200 Sosnowiec, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH